parameters | patients, n(%) |
---|---|
Age (years) | |
  < 60 | 163 (67.1%) |
  > =60 | 80 (32.9%) |
Gender | |
 Female,n(%) | 69 (28.4%) |
 Male,n(%) | 174((71.6%) |
Grade | |
 1–2,n(%) | 143 (58.8%) |
 3–4,n(%) | 100 (41.2%) |
T grade | |
 T1–2,n(%) | 182 (74.9%)) |
 T3–4,n(%) | 61 (25.1%) |
Risk score | |
 Low,n(%) | 123 (50.6%) |
 High,n(%) | 120 (49.4%) |
BMI | |
  < 24,n(%) | 115 (47.3%) |
  > =24,n(%) | 128 (52.7%) |
Race | |
 Asian,n(%) | 126 (51.9%) |
 Non-Asian,n(%) | 117 (48.1%) |
Other Tumor | |
 No,n(%) | 225 (92.6%) |
 Yes,n(%) | 18 (7.4%) |
Cancer status | |
 Tumor Free,n(%) | 162 (66.7%) |
 With Tumor,n(%) | 81 (33.4%) |
HCC risk factor | |
 No,n(%) | 55 (22.6%) |
 Yes,n(%) | 188 (77.4%) |
Surgical method | |
 Lobectomy,n(%) | 94 (38.7%) |
 Non-Lobectomy,n(%) | 149 (61.3%) |
Residual tumor | |
 R0,n(%) | 230 (94.7%) |
 No R0,n(%) | 13 (5.3%) |
New tumor event | |
 No,n(%) | 105 (43.2%) |
 Yes,n(%) | 138 (56.8%) |